Page last updated: 2024-08-17

tributyrin and Breast Neoplasms

tributyrin has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caetano, PA; Carneiro, G; de Souza-Fagundes, EM; Ferreira Costa, D; Ferreira, LA; Gomes, DA; Goulart, G; Silva, EL	1

Other Studies

1 other study(ies) available for tributyrin and Breast Neoplasms

Article	Year
Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid. Expert review of anticancer therapy, 2015, Volume: 15, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Combinations; Female; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Jurkat Cells; Leukemia; Lipids; MCF-7 Cells; Nanostructures; Tretinoin; Triglycerides	2015

Article

Year

Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.

Expert review of anticancer therapy, 2015, Volume: 15, Issue:2

Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Combinations; Female; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Jurkat Cells; Leukemia; Lipids; MCF-7 Cells; Nanostructures; Tretinoin; Triglycerides

2015